ANN THORAC SURG 润色咨询

ANNALS OF THORACIC SURGERY

出版年份:暂无数据 年文章数:9004 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:13.2% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1210048, encodeId=5cdd121004866, content=投了篇少见病例的case serial,一周后送审都没有直接给拒了,说是因为样本量太少还没有对照组……感觉类似类型的文章就不要太指望了,人家根本看不上,连审都不送。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbfd5621633, createdName=ms9000000799627797, createdTime=Sun Apr 10 16:08:53 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212008, encodeId=3fca121200811, content=一般Decision in Process阶段要多久,这是要拒稿的前兆吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17495529301, createdName=libing2013, createdTime=Sun Apr 17 22:21:28 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076853, encodeId=37d310e6853ba, content=with editor20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a2c5305840, createdName=14877f0fm82暂无昵称, createdTime=Sat Dec 04 15:14:10 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069675, encodeId=eeca10696e50a, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:心胸外科<br>经验分享:一审2个月(大修),二审2个月(小修),返修后半个月接收,之后等待见刊时间会比较漫长。注重创新性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJaicGoPL4gRLibjrGJ6NViacZ9ZhGgUVTU3cClwuaUqUjB2BBSHqiaMknDicckus13ZHgf1t8XBqS5gAw/132, createdBy=cfc11961463, createdName=wangzzzzzzz, createdTime=Fri Nov 12 16:06:55 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057118, encodeId=2cde105e1188a, content=偏重的研究方向:胸腔外科;胸外科<br>经验分享:请问前辈们,这本杂志投出去一般with editor多久送审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Sun Oct 03 14:59:39 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552010, encodeId=94ff55201025, content=需要提供原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=312, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAKRcycZj5TgibHLqoLic8zCf69Ffa4DofbTqhibfZMptfLGFU0iawDEYasjWDNcGKcvfbfmHVjTbkkQ/132, createdBy=46c52015377, createdName=我是医学神, createdTime=Thu Jan 25 20:55:00 CST 2018, time=2018-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518964, encodeId=ef6751896493, content=审稿速度:3.0<br>经验分享:这个期刊是胸外科专科领域的顶级三大期刊之一。我个人的投稿经历就是感觉有两点。一,严格。二,编辑非常友好。我一点都没有感觉到前面站友说到的歧视的问题。去年10月14日投稿,一审1个月3天,四个审稿人给了及其详细的意见,小修。11月30日修回,期间由于圣诞及新年耽误了一段时间,今年1月4日接受。语言要求确实较高,润色很有必要的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295f1662192, createdName=Rivers Lee, createdTime=Mon Feb 01 21:30:00 CST 2016, time=2016-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573354, encodeId=ac065e3354a6, content=小修后多久接收的呢?<span class="quote">156qvWc1738(暂无昵称) 2019-01-03 发表::<br>我最近也投了一篇case,20多天with editor后直接decision,现在在小修</span><span class="quote">156qvWc1738(暂无昵称) 2019-01-03 00:00:00 发表:<br>我最近也投了一篇case,20多天with editor后直接decision,现在在小修</span>, beContent=156qvWc1738(暂无昵称) 2019-01-03 发表:: 我最近也投了一篇case,20多天with editor后直接decision,现在在小修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b622454706, createdName=12400f3bm31暂无昵称, createdTime=Fri Jul 05 00:00:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973774, encodeId=d9de9e3774d5, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:肺癌<br>经验分享:第一次投稿就接收了,分享一下自己的投稿过程:26/9投稿 4/10 With Editor 10/10 Under Review 28/12 Decision in process 31/12/2020 Revised 8/1/2021 Under Review 22/4 Accepted 5/5 Online 总体来说,胸外科的顶刊,很注重创新性,审稿周期较长,一般需半年左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70b95282001, createdName=14845858m75(暂无昵称), createdTime=Tue Jun 15 17:00:43 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561412, encodeId=7eec561412eb, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:胸心血管外科领域的老牌期刊,认可度很高,仅次于JTCVS。今年真的非常幸运,上半年同期投了2篇original article,均为一审3个月后大修,第一次修回后再次审稿1个月,再次修回后继续审稿1个月。之后收到接受邮件。算了下时间,每一篇差不多历时7个月左右。总的来说,耗时还是有些长,着急毕业的同学避开好一些,以免发生意外。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3033950, createdName=tuodi1986xjtu, createdTime=Mon Sep 24 23:20:00 CST 2018, time=2018-09-24, status=1, ipAttribution=)]
    2022-04-10 ms9000000799627797

    投了篇少见病例的case serial,一周后送审都没有直接给拒了,说是因为样本量太少还没有对照组……感觉类似类型的文章就不要太指望了,人家根本看不上,连审都不送。

    3

    展开3条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1210048, encodeId=5cdd121004866, content=投了篇少见病例的case serial,一周后送审都没有直接给拒了,说是因为样本量太少还没有对照组……感觉类似类型的文章就不要太指望了,人家根本看不上,连审都不送。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbfd5621633, createdName=ms9000000799627797, createdTime=Sun Apr 10 16:08:53 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212008, encodeId=3fca121200811, content=一般Decision in Process阶段要多久,这是要拒稿的前兆吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17495529301, createdName=libing2013, createdTime=Sun Apr 17 22:21:28 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076853, encodeId=37d310e6853ba, content=with editor20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a2c5305840, createdName=14877f0fm82暂无昵称, createdTime=Sat Dec 04 15:14:10 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069675, encodeId=eeca10696e50a, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:心胸外科<br>经验分享:一审2个月(大修),二审2个月(小修),返修后半个月接收,之后等待见刊时间会比较漫长。注重创新性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJaicGoPL4gRLibjrGJ6NViacZ9ZhGgUVTU3cClwuaUqUjB2BBSHqiaMknDicckus13ZHgf1t8XBqS5gAw/132, createdBy=cfc11961463, createdName=wangzzzzzzz, createdTime=Fri Nov 12 16:06:55 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057118, encodeId=2cde105e1188a, content=偏重的研究方向:胸腔外科;胸外科<br>经验分享:请问前辈们,这本杂志投出去一般with editor多久送审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Sun Oct 03 14:59:39 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552010, encodeId=94ff55201025, content=需要提供原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=312, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAKRcycZj5TgibHLqoLic8zCf69Ffa4DofbTqhibfZMptfLGFU0iawDEYasjWDNcGKcvfbfmHVjTbkkQ/132, createdBy=46c52015377, createdName=我是医学神, createdTime=Thu Jan 25 20:55:00 CST 2018, time=2018-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518964, encodeId=ef6751896493, content=审稿速度:3.0<br>经验分享:这个期刊是胸外科专科领域的顶级三大期刊之一。我个人的投稿经历就是感觉有两点。一,严格。二,编辑非常友好。我一点都没有感觉到前面站友说到的歧视的问题。去年10月14日投稿,一审1个月3天,四个审稿人给了及其详细的意见,小修。11月30日修回,期间由于圣诞及新年耽误了一段时间,今年1月4日接受。语言要求确实较高,润色很有必要的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295f1662192, createdName=Rivers Lee, createdTime=Mon Feb 01 21:30:00 CST 2016, time=2016-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573354, encodeId=ac065e3354a6, content=小修后多久接收的呢?<span class="quote">156qvWc1738(暂无昵称) 2019-01-03 发表::<br>我最近也投了一篇case,20多天with editor后直接decision,现在在小修</span><span class="quote">156qvWc1738(暂无昵称) 2019-01-03 00:00:00 发表:<br>我最近也投了一篇case,20多天with editor后直接decision,现在在小修</span>, beContent=156qvWc1738(暂无昵称) 2019-01-03 发表:: 我最近也投了一篇case,20多天with editor后直接decision,现在在小修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b622454706, createdName=12400f3bm31暂无昵称, createdTime=Fri Jul 05 00:00:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973774, encodeId=d9de9e3774d5, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:肺癌<br>经验分享:第一次投稿就接收了,分享一下自己的投稿过程:26/9投稿 4/10 With Editor 10/10 Under Review 28/12 Decision in process 31/12/2020 Revised 8/1/2021 Under Review 22/4 Accepted 5/5 Online 总体来说,胸外科的顶刊,很注重创新性,审稿周期较长,一般需半年左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70b95282001, createdName=14845858m75(暂无昵称), createdTime=Tue Jun 15 17:00:43 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561412, encodeId=7eec561412eb, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:胸心血管外科领域的老牌期刊,认可度很高,仅次于JTCVS。今年真的非常幸运,上半年同期投了2篇original article,均为一审3个月后大修,第一次修回后再次审稿1个月,再次修回后继续审稿1个月。之后收到接受邮件。算了下时间,每一篇差不多历时7个月左右。总的来说,耗时还是有些长,着急毕业的同学避开好一些,以免发生意外。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3033950, createdName=tuodi1986xjtu, createdTime=Mon Sep 24 23:20:00 CST 2018, time=2018-09-24, status=1, ipAttribution=)]
    2022-04-17 libing2013

    一般Decision in Process阶段要多久,这是要拒稿的前兆吗?

    4

    展开4条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1210048, encodeId=5cdd121004866, content=投了篇少见病例的case serial,一周后送审都没有直接给拒了,说是因为样本量太少还没有对照组……感觉类似类型的文章就不要太指望了,人家根本看不上,连审都不送。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbfd5621633, createdName=ms9000000799627797, createdTime=Sun Apr 10 16:08:53 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212008, encodeId=3fca121200811, content=一般Decision in Process阶段要多久,这是要拒稿的前兆吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17495529301, createdName=libing2013, createdTime=Sun Apr 17 22:21:28 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076853, encodeId=37d310e6853ba, content=with editor20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a2c5305840, createdName=14877f0fm82暂无昵称, createdTime=Sat Dec 04 15:14:10 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069675, encodeId=eeca10696e50a, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:心胸外科<br>经验分享:一审2个月(大修),二审2个月(小修),返修后半个月接收,之后等待见刊时间会比较漫长。注重创新性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJaicGoPL4gRLibjrGJ6NViacZ9ZhGgUVTU3cClwuaUqUjB2BBSHqiaMknDicckus13ZHgf1t8XBqS5gAw/132, createdBy=cfc11961463, createdName=wangzzzzzzz, createdTime=Fri Nov 12 16:06:55 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057118, encodeId=2cde105e1188a, content=偏重的研究方向:胸腔外科;胸外科<br>经验分享:请问前辈们,这本杂志投出去一般with editor多久送审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Sun Oct 03 14:59:39 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552010, encodeId=94ff55201025, content=需要提供原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=312, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAKRcycZj5TgibHLqoLic8zCf69Ffa4DofbTqhibfZMptfLGFU0iawDEYasjWDNcGKcvfbfmHVjTbkkQ/132, createdBy=46c52015377, createdName=我是医学神, createdTime=Thu Jan 25 20:55:00 CST 2018, time=2018-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518964, encodeId=ef6751896493, content=审稿速度:3.0<br>经验分享:这个期刊是胸外科专科领域的顶级三大期刊之一。我个人的投稿经历就是感觉有两点。一,严格。二,编辑非常友好。我一点都没有感觉到前面站友说到的歧视的问题。去年10月14日投稿,一审1个月3天,四个审稿人给了及其详细的意见,小修。11月30日修回,期间由于圣诞及新年耽误了一段时间,今年1月4日接受。语言要求确实较高,润色很有必要的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295f1662192, createdName=Rivers Lee, createdTime=Mon Feb 01 21:30:00 CST 2016, time=2016-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573354, encodeId=ac065e3354a6, content=小修后多久接收的呢?<span class="quote">156qvWc1738(暂无昵称) 2019-01-03 发表::<br>我最近也投了一篇case,20多天with editor后直接decision,现在在小修</span><span class="quote">156qvWc1738(暂无昵称) 2019-01-03 00:00:00 发表:<br>我最近也投了一篇case,20多天with editor后直接decision,现在在小修</span>, beContent=156qvWc1738(暂无昵称) 2019-01-03 发表:: 我最近也投了一篇case,20多天with editor后直接decision,现在在小修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b622454706, createdName=12400f3bm31暂无昵称, createdTime=Fri Jul 05 00:00:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973774, encodeId=d9de9e3774d5, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:肺癌<br>经验分享:第一次投稿就接收了,分享一下自己的投稿过程:26/9投稿 4/10 With Editor 10/10 Under Review 28/12 Decision in process 31/12/2020 Revised 8/1/2021 Under Review 22/4 Accepted 5/5 Online 总体来说,胸外科的顶刊,很注重创新性,审稿周期较长,一般需半年左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70b95282001, createdName=14845858m75(暂无昵称), createdTime=Tue Jun 15 17:00:43 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561412, encodeId=7eec561412eb, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:胸心血管外科领域的老牌期刊,认可度很高,仅次于JTCVS。今年真的非常幸运,上半年同期投了2篇original article,均为一审3个月后大修,第一次修回后再次审稿1个月,再次修回后继续审稿1个月。之后收到接受邮件。算了下时间,每一篇差不多历时7个月左右。总的来说,耗时还是有些长,着急毕业的同学避开好一些,以免发生意外。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3033950, createdName=tuodi1986xjtu, createdTime=Mon Sep 24 23:20:00 CST 2018, time=2018-09-24, status=1, ipAttribution=)]
    2021-12-04 14877f0fm82暂无昵称

    with editor20天了

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1210048, encodeId=5cdd121004866, content=投了篇少见病例的case serial,一周后送审都没有直接给拒了,说是因为样本量太少还没有对照组……感觉类似类型的文章就不要太指望了,人家根本看不上,连审都不送。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbfd5621633, createdName=ms9000000799627797, createdTime=Sun Apr 10 16:08:53 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212008, encodeId=3fca121200811, content=一般Decision in Process阶段要多久,这是要拒稿的前兆吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17495529301, createdName=libing2013, createdTime=Sun Apr 17 22:21:28 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076853, encodeId=37d310e6853ba, content=with editor20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a2c5305840, createdName=14877f0fm82暂无昵称, createdTime=Sat Dec 04 15:14:10 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069675, encodeId=eeca10696e50a, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:心胸外科<br>经验分享:一审2个月(大修),二审2个月(小修),返修后半个月接收,之后等待见刊时间会比较漫长。注重创新性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJaicGoPL4gRLibjrGJ6NViacZ9ZhGgUVTU3cClwuaUqUjB2BBSHqiaMknDicckus13ZHgf1t8XBqS5gAw/132, createdBy=cfc11961463, createdName=wangzzzzzzz, createdTime=Fri Nov 12 16:06:55 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057118, encodeId=2cde105e1188a, content=偏重的研究方向:胸腔外科;胸外科<br>经验分享:请问前辈们,这本杂志投出去一般with editor多久送审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Sun Oct 03 14:59:39 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552010, encodeId=94ff55201025, content=需要提供原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=312, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAKRcycZj5TgibHLqoLic8zCf69Ffa4DofbTqhibfZMptfLGFU0iawDEYasjWDNcGKcvfbfmHVjTbkkQ/132, createdBy=46c52015377, createdName=我是医学神, createdTime=Thu Jan 25 20:55:00 CST 2018, time=2018-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518964, encodeId=ef6751896493, content=审稿速度:3.0<br>经验分享:这个期刊是胸外科专科领域的顶级三大期刊之一。我个人的投稿经历就是感觉有两点。一,严格。二,编辑非常友好。我一点都没有感觉到前面站友说到的歧视的问题。去年10月14日投稿,一审1个月3天,四个审稿人给了及其详细的意见,小修。11月30日修回,期间由于圣诞及新年耽误了一段时间,今年1月4日接受。语言要求确实较高,润色很有必要的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295f1662192, createdName=Rivers Lee, createdTime=Mon Feb 01 21:30:00 CST 2016, time=2016-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573354, encodeId=ac065e3354a6, content=小修后多久接收的呢?<span class="quote">156qvWc1738(暂无昵称) 2019-01-03 发表::<br>我最近也投了一篇case,20多天with editor后直接decision,现在在小修</span><span class="quote">156qvWc1738(暂无昵称) 2019-01-03 00:00:00 发表:<br>我最近也投了一篇case,20多天with editor后直接decision,现在在小修</span>, beContent=156qvWc1738(暂无昵称) 2019-01-03 发表:: 我最近也投了一篇case,20多天with editor后直接decision,现在在小修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b622454706, createdName=12400f3bm31暂无昵称, createdTime=Fri Jul 05 00:00:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973774, encodeId=d9de9e3774d5, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:肺癌<br>经验分享:第一次投稿就接收了,分享一下自己的投稿过程:26/9投稿 4/10 With Editor 10/10 Under Review 28/12 Decision in process 31/12/2020 Revised 8/1/2021 Under Review 22/4 Accepted 5/5 Online 总体来说,胸外科的顶刊,很注重创新性,审稿周期较长,一般需半年左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70b95282001, createdName=14845858m75(暂无昵称), createdTime=Tue Jun 15 17:00:43 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561412, encodeId=7eec561412eb, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:胸心血管外科领域的老牌期刊,认可度很高,仅次于JTCVS。今年真的非常幸运,上半年同期投了2篇original article,均为一审3个月后大修,第一次修回后再次审稿1个月,再次修回后继续审稿1个月。之后收到接受邮件。算了下时间,每一篇差不多历时7个月左右。总的来说,耗时还是有些长,着急毕业的同学避开好一些,以免发生意外。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3033950, createdName=tuodi1986xjtu, createdTime=Mon Sep 24 23:20:00 CST 2018, time=2018-09-24, status=1, ipAttribution=)]
    2021-11-12 wangzzzzzzz

    审稿速度:3.0 | 投稿命中率:25.0
    偏重的研究方向:心胸外科
    经验分享:一审2个月(大修),二审2个月(小修),返修后半个月接收,之后等待见刊时间会比较漫长。注重创新性。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1210048, encodeId=5cdd121004866, content=投了篇少见病例的case serial,一周后送审都没有直接给拒了,说是因为样本量太少还没有对照组……感觉类似类型的文章就不要太指望了,人家根本看不上,连审都不送。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbfd5621633, createdName=ms9000000799627797, createdTime=Sun Apr 10 16:08:53 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212008, encodeId=3fca121200811, content=一般Decision in Process阶段要多久,这是要拒稿的前兆吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17495529301, createdName=libing2013, createdTime=Sun Apr 17 22:21:28 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076853, encodeId=37d310e6853ba, content=with editor20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a2c5305840, createdName=14877f0fm82暂无昵称, createdTime=Sat Dec 04 15:14:10 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069675, encodeId=eeca10696e50a, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:心胸外科<br>经验分享:一审2个月(大修),二审2个月(小修),返修后半个月接收,之后等待见刊时间会比较漫长。注重创新性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJaicGoPL4gRLibjrGJ6NViacZ9ZhGgUVTU3cClwuaUqUjB2BBSHqiaMknDicckus13ZHgf1t8XBqS5gAw/132, createdBy=cfc11961463, createdName=wangzzzzzzz, createdTime=Fri Nov 12 16:06:55 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057118, encodeId=2cde105e1188a, content=偏重的研究方向:胸腔外科;胸外科<br>经验分享:请问前辈们,这本杂志投出去一般with editor多久送审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Sun Oct 03 14:59:39 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552010, encodeId=94ff55201025, content=需要提供原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=312, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAKRcycZj5TgibHLqoLic8zCf69Ffa4DofbTqhibfZMptfLGFU0iawDEYasjWDNcGKcvfbfmHVjTbkkQ/132, createdBy=46c52015377, createdName=我是医学神, createdTime=Thu Jan 25 20:55:00 CST 2018, time=2018-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518964, encodeId=ef6751896493, content=审稿速度:3.0<br>经验分享:这个期刊是胸外科专科领域的顶级三大期刊之一。我个人的投稿经历就是感觉有两点。一,严格。二,编辑非常友好。我一点都没有感觉到前面站友说到的歧视的问题。去年10月14日投稿,一审1个月3天,四个审稿人给了及其详细的意见,小修。11月30日修回,期间由于圣诞及新年耽误了一段时间,今年1月4日接受。语言要求确实较高,润色很有必要的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295f1662192, createdName=Rivers Lee, createdTime=Mon Feb 01 21:30:00 CST 2016, time=2016-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573354, encodeId=ac065e3354a6, content=小修后多久接收的呢?<span class="quote">156qvWc1738(暂无昵称) 2019-01-03 发表::<br>我最近也投了一篇case,20多天with editor后直接decision,现在在小修</span><span class="quote">156qvWc1738(暂无昵称) 2019-01-03 00:00:00 发表:<br>我最近也投了一篇case,20多天with editor后直接decision,现在在小修</span>, beContent=156qvWc1738(暂无昵称) 2019-01-03 发表:: 我最近也投了一篇case,20多天with editor后直接decision,现在在小修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b622454706, createdName=12400f3bm31暂无昵称, createdTime=Fri Jul 05 00:00:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973774, encodeId=d9de9e3774d5, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:肺癌<br>经验分享:第一次投稿就接收了,分享一下自己的投稿过程:26/9投稿 4/10 With Editor 10/10 Under Review 28/12 Decision in process 31/12/2020 Revised 8/1/2021 Under Review 22/4 Accepted 5/5 Online 总体来说,胸外科的顶刊,很注重创新性,审稿周期较长,一般需半年左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70b95282001, createdName=14845858m75(暂无昵称), createdTime=Tue Jun 15 17:00:43 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561412, encodeId=7eec561412eb, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:胸心血管外科领域的老牌期刊,认可度很高,仅次于JTCVS。今年真的非常幸运,上半年同期投了2篇original article,均为一审3个月后大修,第一次修回后再次审稿1个月,再次修回后继续审稿1个月。之后收到接受邮件。算了下时间,每一篇差不多历时7个月左右。总的来说,耗时还是有些长,着急毕业的同学避开好一些,以免发生意外。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3033950, createdName=tuodi1986xjtu, createdTime=Mon Sep 24 23:20:00 CST 2018, time=2018-09-24, status=1, ipAttribution=)]
    2021-10-03 ms7000000117561646

    偏重的研究方向:胸腔外科;胸外科
    经验分享:请问前辈们,这本杂志投出去一般with editor多久送审?

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1210048, encodeId=5cdd121004866, content=投了篇少见病例的case serial,一周后送审都没有直接给拒了,说是因为样本量太少还没有对照组……感觉类似类型的文章就不要太指望了,人家根本看不上,连审都不送。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbfd5621633, createdName=ms9000000799627797, createdTime=Sun Apr 10 16:08:53 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212008, encodeId=3fca121200811, content=一般Decision in Process阶段要多久,这是要拒稿的前兆吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17495529301, createdName=libing2013, createdTime=Sun Apr 17 22:21:28 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076853, encodeId=37d310e6853ba, content=with editor20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a2c5305840, createdName=14877f0fm82暂无昵称, createdTime=Sat Dec 04 15:14:10 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069675, encodeId=eeca10696e50a, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:心胸外科<br>经验分享:一审2个月(大修),二审2个月(小修),返修后半个月接收,之后等待见刊时间会比较漫长。注重创新性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJaicGoPL4gRLibjrGJ6NViacZ9ZhGgUVTU3cClwuaUqUjB2BBSHqiaMknDicckus13ZHgf1t8XBqS5gAw/132, createdBy=cfc11961463, createdName=wangzzzzzzz, createdTime=Fri Nov 12 16:06:55 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057118, encodeId=2cde105e1188a, content=偏重的研究方向:胸腔外科;胸外科<br>经验分享:请问前辈们,这本杂志投出去一般with editor多久送审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Sun Oct 03 14:59:39 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552010, encodeId=94ff55201025, content=需要提供原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=312, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAKRcycZj5TgibHLqoLic8zCf69Ffa4DofbTqhibfZMptfLGFU0iawDEYasjWDNcGKcvfbfmHVjTbkkQ/132, createdBy=46c52015377, createdName=我是医学神, createdTime=Thu Jan 25 20:55:00 CST 2018, time=2018-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518964, encodeId=ef6751896493, content=审稿速度:3.0<br>经验分享:这个期刊是胸外科专科领域的顶级三大期刊之一。我个人的投稿经历就是感觉有两点。一,严格。二,编辑非常友好。我一点都没有感觉到前面站友说到的歧视的问题。去年10月14日投稿,一审1个月3天,四个审稿人给了及其详细的意见,小修。11月30日修回,期间由于圣诞及新年耽误了一段时间,今年1月4日接受。语言要求确实较高,润色很有必要的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295f1662192, createdName=Rivers Lee, createdTime=Mon Feb 01 21:30:00 CST 2016, time=2016-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573354, encodeId=ac065e3354a6, content=小修后多久接收的呢?<span class="quote">156qvWc1738(暂无昵称) 2019-01-03 发表::<br>我最近也投了一篇case,20多天with editor后直接decision,现在在小修</span><span class="quote">156qvWc1738(暂无昵称) 2019-01-03 00:00:00 发表:<br>我最近也投了一篇case,20多天with editor后直接decision,现在在小修</span>, beContent=156qvWc1738(暂无昵称) 2019-01-03 发表:: 我最近也投了一篇case,20多天with editor后直接decision,现在在小修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b622454706, createdName=12400f3bm31暂无昵称, createdTime=Fri Jul 05 00:00:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973774, encodeId=d9de9e3774d5, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:肺癌<br>经验分享:第一次投稿就接收了,分享一下自己的投稿过程:26/9投稿 4/10 With Editor 10/10 Under Review 28/12 Decision in process 31/12/2020 Revised 8/1/2021 Under Review 22/4 Accepted 5/5 Online 总体来说,胸外科的顶刊,很注重创新性,审稿周期较长,一般需半年左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70b95282001, createdName=14845858m75(暂无昵称), createdTime=Tue Jun 15 17:00:43 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561412, encodeId=7eec561412eb, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:胸心血管外科领域的老牌期刊,认可度很高,仅次于JTCVS。今年真的非常幸运,上半年同期投了2篇original article,均为一审3个月后大修,第一次修回后再次审稿1个月,再次修回后继续审稿1个月。之后收到接受邮件。算了下时间,每一篇差不多历时7个月左右。总的来说,耗时还是有些长,着急毕业的同学避开好一些,以免发生意外。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3033950, createdName=tuodi1986xjtu, createdTime=Mon Sep 24 23:20:00 CST 2018, time=2018-09-24, status=1, ipAttribution=)]
    2018-01-25 我是医学神

    需要提供原始数据嘛

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=1210048, encodeId=5cdd121004866, content=投了篇少见病例的case serial,一周后送审都没有直接给拒了,说是因为样本量太少还没有对照组……感觉类似类型的文章就不要太指望了,人家根本看不上,连审都不送。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbfd5621633, createdName=ms9000000799627797, createdTime=Sun Apr 10 16:08:53 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212008, encodeId=3fca121200811, content=一般Decision in Process阶段要多久,这是要拒稿的前兆吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17495529301, createdName=libing2013, createdTime=Sun Apr 17 22:21:28 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076853, encodeId=37d310e6853ba, content=with editor20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a2c5305840, createdName=14877f0fm82暂无昵称, createdTime=Sat Dec 04 15:14:10 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069675, encodeId=eeca10696e50a, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:心胸外科<br>经验分享:一审2个月(大修),二审2个月(小修),返修后半个月接收,之后等待见刊时间会比较漫长。注重创新性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJaicGoPL4gRLibjrGJ6NViacZ9ZhGgUVTU3cClwuaUqUjB2BBSHqiaMknDicckus13ZHgf1t8XBqS5gAw/132, createdBy=cfc11961463, createdName=wangzzzzzzz, createdTime=Fri Nov 12 16:06:55 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057118, encodeId=2cde105e1188a, content=偏重的研究方向:胸腔外科;胸外科<br>经验分享:请问前辈们,这本杂志投出去一般with editor多久送审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Sun Oct 03 14:59:39 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552010, encodeId=94ff55201025, content=需要提供原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=312, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAKRcycZj5TgibHLqoLic8zCf69Ffa4DofbTqhibfZMptfLGFU0iawDEYasjWDNcGKcvfbfmHVjTbkkQ/132, createdBy=46c52015377, createdName=我是医学神, createdTime=Thu Jan 25 20:55:00 CST 2018, time=2018-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518964, encodeId=ef6751896493, content=审稿速度:3.0<br>经验分享:这个期刊是胸外科专科领域的顶级三大期刊之一。我个人的投稿经历就是感觉有两点。一,严格。二,编辑非常友好。我一点都没有感觉到前面站友说到的歧视的问题。去年10月14日投稿,一审1个月3天,四个审稿人给了及其详细的意见,小修。11月30日修回,期间由于圣诞及新年耽误了一段时间,今年1月4日接受。语言要求确实较高,润色很有必要的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295f1662192, createdName=Rivers Lee, createdTime=Mon Feb 01 21:30:00 CST 2016, time=2016-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573354, encodeId=ac065e3354a6, content=小修后多久接收的呢?<span class="quote">156qvWc1738(暂无昵称) 2019-01-03 发表::<br>我最近也投了一篇case,20多天with editor后直接decision,现在在小修</span><span class="quote">156qvWc1738(暂无昵称) 2019-01-03 00:00:00 发表:<br>我最近也投了一篇case,20多天with editor后直接decision,现在在小修</span>, beContent=156qvWc1738(暂无昵称) 2019-01-03 发表:: 我最近也投了一篇case,20多天with editor后直接decision,现在在小修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b622454706, createdName=12400f3bm31暂无昵称, createdTime=Fri Jul 05 00:00:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973774, encodeId=d9de9e3774d5, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:肺癌<br>经验分享:第一次投稿就接收了,分享一下自己的投稿过程:26/9投稿 4/10 With Editor 10/10 Under Review 28/12 Decision in process 31/12/2020 Revised 8/1/2021 Under Review 22/4 Accepted 5/5 Online 总体来说,胸外科的顶刊,很注重创新性,审稿周期较长,一般需半年左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70b95282001, createdName=14845858m75(暂无昵称), createdTime=Tue Jun 15 17:00:43 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561412, encodeId=7eec561412eb, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:胸心血管外科领域的老牌期刊,认可度很高,仅次于JTCVS。今年真的非常幸运,上半年同期投了2篇original article,均为一审3个月后大修,第一次修回后再次审稿1个月,再次修回后继续审稿1个月。之后收到接受邮件。算了下时间,每一篇差不多历时7个月左右。总的来说,耗时还是有些长,着急毕业的同学避开好一些,以免发生意外。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3033950, createdName=tuodi1986xjtu, createdTime=Mon Sep 24 23:20:00 CST 2018, time=2018-09-24, status=1, ipAttribution=)]
    2016-02-01 Rivers Lee

    审稿速度:3.0
    经验分享:这个期刊是胸外科专科领域的顶级三大期刊之一。我个人的投稿经历就是感觉有两点。一,严格。二,编辑非常友好。我一点都没有感觉到前面站友说到的歧视的问题。去年10月14日投稿,一审1个月3天,四个审稿人给了及其详细的意见,小修。11月30日修回,期间由于圣诞及新年耽误了一段时间,今年1月4日接受。语言要求确实较高,润色很有必要的。

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=1210048, encodeId=5cdd121004866, content=投了篇少见病例的case serial,一周后送审都没有直接给拒了,说是因为样本量太少还没有对照组……感觉类似类型的文章就不要太指望了,人家根本看不上,连审都不送。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbfd5621633, createdName=ms9000000799627797, createdTime=Sun Apr 10 16:08:53 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212008, encodeId=3fca121200811, content=一般Decision in Process阶段要多久,这是要拒稿的前兆吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17495529301, createdName=libing2013, createdTime=Sun Apr 17 22:21:28 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076853, encodeId=37d310e6853ba, content=with editor20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a2c5305840, createdName=14877f0fm82暂无昵称, createdTime=Sat Dec 04 15:14:10 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069675, encodeId=eeca10696e50a, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:心胸外科<br>经验分享:一审2个月(大修),二审2个月(小修),返修后半个月接收,之后等待见刊时间会比较漫长。注重创新性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJaicGoPL4gRLibjrGJ6NViacZ9ZhGgUVTU3cClwuaUqUjB2BBSHqiaMknDicckus13ZHgf1t8XBqS5gAw/132, createdBy=cfc11961463, createdName=wangzzzzzzz, createdTime=Fri Nov 12 16:06:55 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057118, encodeId=2cde105e1188a, content=偏重的研究方向:胸腔外科;胸外科<br>经验分享:请问前辈们,这本杂志投出去一般with editor多久送审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Sun Oct 03 14:59:39 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552010, encodeId=94ff55201025, content=需要提供原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=312, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAKRcycZj5TgibHLqoLic8zCf69Ffa4DofbTqhibfZMptfLGFU0iawDEYasjWDNcGKcvfbfmHVjTbkkQ/132, createdBy=46c52015377, createdName=我是医学神, createdTime=Thu Jan 25 20:55:00 CST 2018, time=2018-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518964, encodeId=ef6751896493, content=审稿速度:3.0<br>经验分享:这个期刊是胸外科专科领域的顶级三大期刊之一。我个人的投稿经历就是感觉有两点。一,严格。二,编辑非常友好。我一点都没有感觉到前面站友说到的歧视的问题。去年10月14日投稿,一审1个月3天,四个审稿人给了及其详细的意见,小修。11月30日修回,期间由于圣诞及新年耽误了一段时间,今年1月4日接受。语言要求确实较高,润色很有必要的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295f1662192, createdName=Rivers Lee, createdTime=Mon Feb 01 21:30:00 CST 2016, time=2016-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573354, encodeId=ac065e3354a6, content=小修后多久接收的呢?<span class="quote">156qvWc1738(暂无昵称) 2019-01-03 发表::<br>我最近也投了一篇case,20多天with editor后直接decision,现在在小修</span><span class="quote">156qvWc1738(暂无昵称) 2019-01-03 00:00:00 发表:<br>我最近也投了一篇case,20多天with editor后直接decision,现在在小修</span>, beContent=156qvWc1738(暂无昵称) 2019-01-03 发表:: 我最近也投了一篇case,20多天with editor后直接decision,现在在小修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b622454706, createdName=12400f3bm31暂无昵称, createdTime=Fri Jul 05 00:00:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973774, encodeId=d9de9e3774d5, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:肺癌<br>经验分享:第一次投稿就接收了,分享一下自己的投稿过程:26/9投稿 4/10 With Editor 10/10 Under Review 28/12 Decision in process 31/12/2020 Revised 8/1/2021 Under Review 22/4 Accepted 5/5 Online 总体来说,胸外科的顶刊,很注重创新性,审稿周期较长,一般需半年左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70b95282001, createdName=14845858m75(暂无昵称), createdTime=Tue Jun 15 17:00:43 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561412, encodeId=7eec561412eb, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:胸心血管外科领域的老牌期刊,认可度很高,仅次于JTCVS。今年真的非常幸运,上半年同期投了2篇original article,均为一审3个月后大修,第一次修回后再次审稿1个月,再次修回后继续审稿1个月。之后收到接受邮件。算了下时间,每一篇差不多历时7个月左右。总的来说,耗时还是有些长,着急毕业的同学避开好一些,以免发生意外。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3033950, createdName=tuodi1986xjtu, createdTime=Mon Sep 24 23:20:00 CST 2018, time=2018-09-24, status=1, ipAttribution=)]
    2019-07-05 12400f3bm31暂无昵称

    小修后多久接收的呢?156qvWc1738(暂无昵称) 2019-01-03 发表::
    我最近也投了一篇case,20多天with editor后直接decision,现在在小修
    156qvWc1738(暂无昵称) 2019-01-03 00:00:00 发表:
    我最近也投了一篇case,20多天with editor后直接decision,现在在小修

    156qvWc1738(暂无昵称) 2019-01-03 发表:: 我最近也投了一篇case,20多天with editor后直接decision,现在在小修

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=1210048, encodeId=5cdd121004866, content=投了篇少见病例的case serial,一周后送审都没有直接给拒了,说是因为样本量太少还没有对照组……感觉类似类型的文章就不要太指望了,人家根本看不上,连审都不送。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbfd5621633, createdName=ms9000000799627797, createdTime=Sun Apr 10 16:08:53 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212008, encodeId=3fca121200811, content=一般Decision in Process阶段要多久,这是要拒稿的前兆吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17495529301, createdName=libing2013, createdTime=Sun Apr 17 22:21:28 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076853, encodeId=37d310e6853ba, content=with editor20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a2c5305840, createdName=14877f0fm82暂无昵称, createdTime=Sat Dec 04 15:14:10 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069675, encodeId=eeca10696e50a, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:心胸外科<br>经验分享:一审2个月(大修),二审2个月(小修),返修后半个月接收,之后等待见刊时间会比较漫长。注重创新性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJaicGoPL4gRLibjrGJ6NViacZ9ZhGgUVTU3cClwuaUqUjB2BBSHqiaMknDicckus13ZHgf1t8XBqS5gAw/132, createdBy=cfc11961463, createdName=wangzzzzzzz, createdTime=Fri Nov 12 16:06:55 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057118, encodeId=2cde105e1188a, content=偏重的研究方向:胸腔外科;胸外科<br>经验分享:请问前辈们,这本杂志投出去一般with editor多久送审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Sun Oct 03 14:59:39 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552010, encodeId=94ff55201025, content=需要提供原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=312, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAKRcycZj5TgibHLqoLic8zCf69Ffa4DofbTqhibfZMptfLGFU0iawDEYasjWDNcGKcvfbfmHVjTbkkQ/132, createdBy=46c52015377, createdName=我是医学神, createdTime=Thu Jan 25 20:55:00 CST 2018, time=2018-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518964, encodeId=ef6751896493, content=审稿速度:3.0<br>经验分享:这个期刊是胸外科专科领域的顶级三大期刊之一。我个人的投稿经历就是感觉有两点。一,严格。二,编辑非常友好。我一点都没有感觉到前面站友说到的歧视的问题。去年10月14日投稿,一审1个月3天,四个审稿人给了及其详细的意见,小修。11月30日修回,期间由于圣诞及新年耽误了一段时间,今年1月4日接受。语言要求确实较高,润色很有必要的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295f1662192, createdName=Rivers Lee, createdTime=Mon Feb 01 21:30:00 CST 2016, time=2016-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573354, encodeId=ac065e3354a6, content=小修后多久接收的呢?<span class="quote">156qvWc1738(暂无昵称) 2019-01-03 发表::<br>我最近也投了一篇case,20多天with editor后直接decision,现在在小修</span><span class="quote">156qvWc1738(暂无昵称) 2019-01-03 00:00:00 发表:<br>我最近也投了一篇case,20多天with editor后直接decision,现在在小修</span>, beContent=156qvWc1738(暂无昵称) 2019-01-03 发表:: 我最近也投了一篇case,20多天with editor后直接decision,现在在小修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b622454706, createdName=12400f3bm31暂无昵称, createdTime=Fri Jul 05 00:00:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973774, encodeId=d9de9e3774d5, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:肺癌<br>经验分享:第一次投稿就接收了,分享一下自己的投稿过程:26/9投稿 4/10 With Editor 10/10 Under Review 28/12 Decision in process 31/12/2020 Revised 8/1/2021 Under Review 22/4 Accepted 5/5 Online 总体来说,胸外科的顶刊,很注重创新性,审稿周期较长,一般需半年左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70b95282001, createdName=14845858m75(暂无昵称), createdTime=Tue Jun 15 17:00:43 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561412, encodeId=7eec561412eb, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:胸心血管外科领域的老牌期刊,认可度很高,仅次于JTCVS。今年真的非常幸运,上半年同期投了2篇original article,均为一审3个月后大修,第一次修回后再次审稿1个月,再次修回后继续审稿1个月。之后收到接受邮件。算了下时间,每一篇差不多历时7个月左右。总的来说,耗时还是有些长,着急毕业的同学避开好一些,以免发生意外。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3033950, createdName=tuodi1986xjtu, createdTime=Mon Sep 24 23:20:00 CST 2018, time=2018-09-24, status=1, ipAttribution=)]
    2021-06-15 14845858m75(暂无昵称)

    审稿速度:3.0 | 投稿命中率:25.0
    偏重的研究方向:肺癌
    经验分享:第一次投稿就接收了,分享一下自己的投稿过程:26/9投稿 4/10 With Editor 10/10 Under Review 28/12 Decision in process 31/12/2020 Revised 8/1/2021 Under Review 22/4 Accepted 5/5 Online 总体来说,胸外科的顶刊,很注重创新性,审稿周期较长,一般需半年左右

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=1210048, encodeId=5cdd121004866, content=投了篇少见病例的case serial,一周后送审都没有直接给拒了,说是因为样本量太少还没有对照组……感觉类似类型的文章就不要太指望了,人家根本看不上,连审都不送。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbfd5621633, createdName=ms9000000799627797, createdTime=Sun Apr 10 16:08:53 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212008, encodeId=3fca121200811, content=一般Decision in Process阶段要多久,这是要拒稿的前兆吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17495529301, createdName=libing2013, createdTime=Sun Apr 17 22:21:28 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076853, encodeId=37d310e6853ba, content=with editor20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a2c5305840, createdName=14877f0fm82暂无昵称, createdTime=Sat Dec 04 15:14:10 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069675, encodeId=eeca10696e50a, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:心胸外科<br>经验分享:一审2个月(大修),二审2个月(小修),返修后半个月接收,之后等待见刊时间会比较漫长。注重创新性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJaicGoPL4gRLibjrGJ6NViacZ9ZhGgUVTU3cClwuaUqUjB2BBSHqiaMknDicckus13ZHgf1t8XBqS5gAw/132, createdBy=cfc11961463, createdName=wangzzzzzzz, createdTime=Fri Nov 12 16:06:55 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057118, encodeId=2cde105e1188a, content=偏重的研究方向:胸腔外科;胸外科<br>经验分享:请问前辈们,这本杂志投出去一般with editor多久送审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Sun Oct 03 14:59:39 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552010, encodeId=94ff55201025, content=需要提供原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=312, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAKRcycZj5TgibHLqoLic8zCf69Ffa4DofbTqhibfZMptfLGFU0iawDEYasjWDNcGKcvfbfmHVjTbkkQ/132, createdBy=46c52015377, createdName=我是医学神, createdTime=Thu Jan 25 20:55:00 CST 2018, time=2018-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518964, encodeId=ef6751896493, content=审稿速度:3.0<br>经验分享:这个期刊是胸外科专科领域的顶级三大期刊之一。我个人的投稿经历就是感觉有两点。一,严格。二,编辑非常友好。我一点都没有感觉到前面站友说到的歧视的问题。去年10月14日投稿,一审1个月3天,四个审稿人给了及其详细的意见,小修。11月30日修回,期间由于圣诞及新年耽误了一段时间,今年1月4日接受。语言要求确实较高,润色很有必要的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=448, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295f1662192, createdName=Rivers Lee, createdTime=Mon Feb 01 21:30:00 CST 2016, time=2016-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573354, encodeId=ac065e3354a6, content=小修后多久接收的呢?<span class="quote">156qvWc1738(暂无昵称) 2019-01-03 发表::<br>我最近也投了一篇case,20多天with editor后直接decision,现在在小修</span><span class="quote">156qvWc1738(暂无昵称) 2019-01-03 00:00:00 发表:<br>我最近也投了一篇case,20多天with editor后直接decision,现在在小修</span>, beContent=156qvWc1738(暂无昵称) 2019-01-03 发表:: 我最近也投了一篇case,20多天with editor后直接decision,现在在小修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b622454706, createdName=12400f3bm31暂无昵称, createdTime=Fri Jul 05 00:00:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973774, encodeId=d9de9e3774d5, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:肺癌<br>经验分享:第一次投稿就接收了,分享一下自己的投稿过程:26/9投稿 4/10 With Editor 10/10 Under Review 28/12 Decision in process 31/12/2020 Revised 8/1/2021 Under Review 22/4 Accepted 5/5 Online 总体来说,胸外科的顶刊,很注重创新性,审稿周期较长,一般需半年左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70b95282001, createdName=14845858m75(暂无昵称), createdTime=Tue Jun 15 17:00:43 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561412, encodeId=7eec561412eb, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:胸心血管外科领域的老牌期刊,认可度很高,仅次于JTCVS。今年真的非常幸运,上半年同期投了2篇original article,均为一审3个月后大修,第一次修回后再次审稿1个月,再次修回后继续审稿1个月。之后收到接受邮件。算了下时间,每一篇差不多历时7个月左右。总的来说,耗时还是有些长,着急毕业的同学避开好一些,以免发生意外。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=339, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3033950, createdName=tuodi1986xjtu, createdTime=Mon Sep 24 23:20:00 CST 2018, time=2018-09-24, status=1, ipAttribution=)]
    2018-09-24 tuodi1986xjtu

    审稿速度:3.0 | 投稿命中率:50.0
    经验分享:胸心血管外科领域的老牌期刊,认可度很高,仅次于JTCVS。今年真的非常幸运,上半年同期投了2篇original article,均为一审3个月后大修,第一次修回后再次审稿1个月,再次修回后继续审稿1个月。之后收到接受邮件。算了下时间,每一篇差不多历时7个月左右。总的来说,耗时还是有些长,着急毕业的同学避开好一些,以免发生意外。

    3

    展开3条回复
共65条页码: 1/7页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分